PortalPublikationenTocilizumab treatment for polyarteritis nodosa

Tocilizumab treatment for polyarteritis nodosa

Standard

Tocilizumab treatment for polyarteritis nodosa. / Krusche, Martin; Ruffer, Nikolas; Schneider, Udo; Meyer, Marco; Burmester, Gerd; Kötter, Ina.

in: RHEUMATOLOGY, Jahrgang 59, Nr. 10, 01.10.2020, S. e63-e65.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung

Harvard

Krusche, M, Ruffer, N, Schneider, U, Meyer, M, Burmester, G & Kötter, I 2020, 'Tocilizumab treatment for polyarteritis nodosa', RHEUMATOLOGY, Jg. 59, Nr. 10, S. e63-e65. https://doi.org/10.1093/rheumatology/keaa079

APA

Krusche, M., Ruffer, N., Schneider, U., Meyer, M., Burmester, G., & Kötter, I. (2020). Tocilizumab treatment for polyarteritis nodosa. RHEUMATOLOGY, 59(10), e63-e65. https://doi.org/10.1093/rheumatology/keaa079

Vancouver

Krusche M, Ruffer N, Schneider U, Meyer M, Burmester G, Kötter I. Tocilizumab treatment for polyarteritis nodosa. RHEUMATOLOGY. 2020 Okt 1;59(10):e63-e65. https://doi.org/10.1093/rheumatology/keaa079

Bibtex

@article{bae23616cfbe45e08e737b47033f05ce,
title = "Tocilizumab treatment for polyarteritis nodosa",
keywords = "Adult, Aftercare, Aged, Antibodies, Monoclonal, Humanized/therapeutic use, C-Reactive Protein/analysis, Drug Therapy, Combination, Female, Glucocorticoids/therapeutic use, Humans, Male, Middle Aged, Musculoskeletal Diseases/etiology, Peripheral Nervous System Diseases/etiology, Polyarteritis Nodosa/complications, Prednisolone/therapeutic use, Receptors, Interleukin-6/antagonists & inhibitors, Remission Induction, Treatment Outcome",
author = "Martin Krusche and Nikolas Ruffer and Udo Schneider and Marco Meyer and Gerd Burmester and Ina K{\"o}tter",
year = "2020",
month = oct,
day = "1",
doi = "10.1093/rheumatology/keaa079",
language = "English",
volume = "59",
pages = "e63--e65",
journal = "RHEUMATOLOGY",
issn = "1462-0324",
publisher = "Oxford University Press",
number = "10",

}

RIS

TY - JOUR

T1 - Tocilizumab treatment for polyarteritis nodosa

AU - Krusche, Martin

AU - Ruffer, Nikolas

AU - Schneider, Udo

AU - Meyer, Marco

AU - Burmester, Gerd

AU - Kötter, Ina

PY - 2020/10/1

Y1 - 2020/10/1

KW - Adult

KW - Aftercare

KW - Aged

KW - Antibodies, Monoclonal, Humanized/therapeutic use

KW - C-Reactive Protein/analysis

KW - Drug Therapy, Combination

KW - Female

KW - Glucocorticoids/therapeutic use

KW - Humans

KW - Male

KW - Middle Aged

KW - Musculoskeletal Diseases/etiology

KW - Peripheral Nervous System Diseases/etiology

KW - Polyarteritis Nodosa/complications

KW - Prednisolone/therapeutic use

KW - Receptors, Interleukin-6/antagonists & inhibitors

KW - Remission Induction

KW - Treatment Outcome

U2 - 10.1093/rheumatology/keaa079

DO - 10.1093/rheumatology/keaa079

M3 - SCORING: Journal article

C2 - 32182367

VL - 59

SP - e63-e65

JO - RHEUMATOLOGY

JF - RHEUMATOLOGY

SN - 1462-0324

IS - 10

ER -